Skip to Content

RX509 (Amoxicillin and Clavulanate 875 mg / 125mg)

Pill imprint RX509 has been identified as Amoxicillin and clavulanate potassium 875 mg / 125mg.

Amoxicillin/clavulanate is used in the treatment of bacterial infection; sinusitis; urinary tract infection; skin or soft tissue infection; bronchiectasis (and more), and belongs to the drug class beta-lactamase inhibitors. There is no proven risk in humans during pregnancy. Amoxicillin/clavulanate 875 mg / 125mg is not a controlled substance under the Controlled Substance Act (CSA).

Amoxicillin and clavulanate potassium 875 mg / 125mg RX509
Amoxicillin and clavulanate potassium
875 mg / 125mg
Elliptical / Oval
Prescription only
Drug Class:
Beta-lactamase inhibitors
Pregnancy Category:
B - No proven risk in humans
CSA Schedule:
Not a controlled drug
Ranbaxy Pharmaceuticals Inc.
National Drug Code (NDC):
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
51079-0267 UDL Laboratories Inc
68084-0236 Amerisource Health Services
57866-3129 Direct Dispensing Inc (repackager)
16590-0020 Stat RX USA LLC (repackager)
58016-4990 Southwood Pharmaceuticals Inc (repackager)
33358-0031 CorePharma, LLC (repackager)
49999-0177 Lake Erie Medical and Surgical Supply (repackager)
43063-0077 PDRX Pharmaceuticals Inc (repackager)
55289-0767 PDRX Pharmaceuticals Inc (repackager)

Note: Inactive ingredients may vary.

View Details Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.